| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_863785e4f0e730175e0f6a095ac08a27 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5153
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 |
| filingDate |
2014-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6872c4cfd0b800e25713950f0fbf74ee |
| publicationDate |
2015-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015066212-A2 |
| titleOfInvention |
Calpain inhibitors for treatment of inflammatory bowel disease and colorectal cancer |
| abstract |
The present disclosure provides a method of treating colitis and colorectal cancer with a m-calpain selective inhibitor. Also described in this disclosure are pharmaceutical compositions comprising a m-calpain selective inhibitor to inhibit m-calpain activity in tumor cells and other cells in the colon. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113413490-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017162798-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113413490-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109276553-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107693505-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107693505-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111789842-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109276553-B |
| priorityDate |
2013-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |